skip to Main Content

SPEAKERS

SAMPLE OF KEYNOTE SPEAKERS AND THEIR CASE STUDIES

Jerome
DREVON-BARREAUX

Head of Procurement France

Bristol-Myers Squibb

CASE STUDY / DAY 1

How Procurement can bring value beyond cost reduction - think out of the box

Procurement shall no longer be perceived as a cost reduction department but rather shall bring value proposition, innovation and mind changing approach.

  • How to market the “new” Procurement approach
  • How to get the right innovation
  • The new way to interact with stakeholders

CASE STUDY / DAY 1

Effective drive of category management in a MNC from a local market perspective
  • Even if category management is an established and mature concept in the procurement landscape, companies are still struggling when it comes to the execution
  • Especially the rollout in multinational organizations creates a major challenge from many procurement teams
  • However, there are ideas and solutions which have shown how to overcome potential challenges, risks and issues
  • Based on authentic examples, these practical ways should be illustrated

Michael
STRÖMER

Head of Robotics - Wholesale Banking

AstraZeneca

This year Summit will host speakers from the world’s leading companies.
See sample of key note speakers.

Michael
STRÖMER

Head of Procurement Germany

AstraZeneca

Karolina
TOPCZEWSKA

Head of Purchasing

Polpharma

Viraj
MEHTA

Procurement Director Global Custom APIs

GSK

Anders
ALBERG

Director, Devices & Needles, Strategic Sourcing

Novo Nordisk

Jerome
DREVON-BARREAUX

Head of Procurement France

Bristol-Myers Squibb

Yoram
ESHEL

Former Senior Director of Logistics

Teva

CASE STUDY / DAY 2

The importance of value creation in Pharmaceutical industry

E2E value creation is viral in pharmaceutical industry which is based on three pillars of innovation, performance and trust. Value creates a value so very important to keep the cycle going on. Every stakeholder plays a significant role on the journey of value creation to ensure that patients globally have access to essential and innovative drugs at all times. Value creates value. Key contributors in E2E value generation:

  • Supply chain sustainability
  • Continuous improvements in cost competitiveness
  • Access to innovation and cater to unmet medical needs
  • Risk mitigation and enhance trust
  • Learning from other industries – “what the best looks like”

Viraj
MEHTA

Procurement Director Global Custom APIs

GSK

Yoram
ESHEL

Former Senior Director of Logistics

Teva

CASE STUDY / DAY 2

Risk Management along Pharma Supply Chain

Every Supply Chain will have its own risk. From physical and quality risks thru compliance, business, international trade, and environmental risks. What makes the pharma supply chain more risky than others? How can we understand, analyze and mitigate those risks? How can we create and implement a long-term “risk avoidance” culture together with our internal and external business partners?

  • Types of risks along the Supply Chain – Internal and External risks
  • Pharmaceuticals and APIs – Risk Analysis and Risk Avoidance
  • Working together with your suppliers – practical aspects of risk mitigation
  • Insurance aspects – How to ensure full coverage
  • Advanced technologies to reduce risks and improve supply chain visibility
FOR MORE INFORMATION REQUEST FULL PROGRAMME

See what keynote speakers will be taking part in the exclusive speaking panel.
Explore what Case Studies will be discussed by our senior corporate speakers

8th Annual Pharma Strategic Sourcing & Procurement Summit
TIME IS RUNNING OUT! DON’T RISK MISSING IT

THANK YOU FOR YOUR CALL REQUEST

You will be contacted shortly.

Back To Top

RELATED EVENTS

14th Annual Chemical/Petrochemical Strategic Sourcing Summit
2nd Annual Supply Chain & Logistics in Chemical/Petrochemical Summit
7th Annual Global Strategic Sourcing & Procurement Summit